Top

Global Stem Cells Group and Santiago University to Launch New Edition of Post-Graduate Diploma Program

stem cell training

MIAMI, April 30, 2015--Global Stem Cells Group and the University of Santiago, Chile have announced plans to launch a new edition of the post-graduate diploma program, “Diplomat in Cell Therapy and Tissue Engineering.” The first of its kind worldwide, the program is designed for physicians and qualified practitioners to bring stem cell therapies into the doctor’s office to treat patients. The University of Santiago, ranked among the top universities in South America, is the first state university to offer a diploma program in stem cells, tissue engineering and cell therapy. The program concentrates on advances in cell biology, the clinical and linked characteristics to bioprocessing of stem cells derived from adipose tissue, and other stem cell-based protocols. Based on medical research that emerged in the late 20th...

Read More

Duncan Ross, Ph.D. Joins Global Stem Cells Group Advisory Board

stem cells, stem cell research, Santiago symposium

Molecular biologist, immunologist and researcher Duncan Ross, Ph.D., founder of Kimera Labs, has joined the Global Stem Cells Group Advisory Board faculty. Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, Ph.D. has joined the GSCG Advisory Board. Ross is the founder of GSCG affiliate Kimera Labs in Miami. In 2004, Ross received his Ph.D. in Immunology from the University of Miami, where he studied hematopoietic stem cell transplantation for hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM Professor Robert Levy Ph.D. Ross was motivated to study in this field after witnessing his father’s experience suffering through unsuccessful treatments for Acute Myeloid Leukemia. Since launching his career in 2004, Ross has investigated various methods of immune suppression, from regulatory T cells...

Read More

Global Stem Cells Group and University of Santiago Biotech Lab Endorse Asia-Pacific Symposium

stem cells, stem cell symposium, Santiago biotech lab

Global Stem Cells Group and the University of Santiago, Chile have endorsed an Asian-Pacific alliance for a regenerative medicine and stem cell symposium July 1-2 at the university’s Santiago campus and other stem cell protocol management initiatives. Through the alliance, the two organizations established a working agenda for collaborative initiatives in stem cell and regenerative medicine research and development for 2016 – 2020. Global Stem Cells Group and the University of Santiago Biotechnology Lab have announced a mutual endorsement of an Asia-Pacific Symposium as other research and development initiatives for potential stem cell protocol management for 2016 – 2020. In 2015, University of Santiago officials and top Global Stem Cells Group executives began meeting to establish a working agenda and foster initiatives to promote stem cell research...

Read More

Global Stem Cells Group Advisory Board Member Duncan Ross, Ph.D., to Speak at Santiago, Chile Symposium

stem cells, stem cell research, Santiago Chile symposium

Global Stem Cells Group Advisory Board member Duncan Ross, Ph.D., founder of Kimera Research Labs, will be the keynote speaker at the Global Stem Cells Group Symposium in Santiago, Chile July 1-2, 2016. MIAMI, April 26, 2016--Global Stem Cells Group has announced that affiliate Kimera Research Labs founder Duncan Ross, Ph.D., a GSCG Advisory Board member, will be the keynote speaker at the Asia-Pacific Symposium in Santiago Chile, July 1-2, 2016. The abstract for Ross's lecture will be, “The mechanism of action of stem cells in regenerative medicine is increasingly being understood to be effected through paracrine factors. Central to the question of when and how to treat an individual disease is where and for what duration a transplanted cell will persist to generate these factors.” In...

Read More

Global Stem Cells Group and Kimera Labs Announce Autologous Stem Cell Research Alliance

Global Stem Cells Group and Kimera Research Labs have announced an alliance to conduct scientific research on highly manipulated cells and culture expansion, and cryopreservation of autologous stem cells. MIAMI, April 26, 2016--Global Stem Cells Group and Kimera Research Labs have announced an alliance to conduct scientific research on highly manipulated stem cells and culture expansion, and cryopreservation of autologous stem cells. The collaboration will open new opportunities for GSCG to increase its participation in scientific research and development of new stem cell protocols and treatments for a number of conditions. The manipulation of stem cells involves the ability to deliver molecules into adherent cells without disrupting differentiation, a process biotechnology researchers need in order to advance both fundamental knowledge and the state-of-the-art in stem cell research....

Read More

Global Stem Cells Group Plans Bone Marrow Clinical Trials for Knee Osteoarthritis

Global Stem Cells Group has announced plans to hold clinical trials, pending IRB approval, for bone marrow stem cell treatments targeting knee osteoarthritis. The trials will be held in five GSCG facilities in the U.S. and South America, with 25 patients accepted for each location. MIAMI, March 31, 2016—Pending Institutional Review Board (IRB) approval, Global Stem Cells Group, Inc. has announced plans to conduct a multi-center, placebo controlled clinical trial to measure the safety and effectiveness of the intra-articular application of freshly isolated bone marrow stem cells for the treatment of osteoarthritis. The clinical trials, which will begin July 1, 2016 and run for one year, will be held in Global Stem Cell Group facilities in Buenos Aires, Argentina; Bogota, Colombia; Quito, Ecuador; Miami, Florida and Topeka,...

Read More

Global Stem Cells Group Announces Manufacturing Phase of Progenikine™ SVF Closed System

Global Stem Cells Group has begun the manufacturing phase of Progenikine™, a new SVF closed system kit utilizing EmCyte technology, containing all the elements necessary to process adipose tissue and obtain stromal vascular fraction in a sterile environment. MIAMI, March 31, 2016—Global Stem Cells Group, Inc. has announced that Progenikine™, its new and approved SVF closed system kit using EmCyte technology, is in the manufacturing phase and will be available to physicians in July 2016. The Progenikine kit contains all the elements necessary to process adipose tissue and obtain stromal vascular fraction (SVF) in a closed environment. Adipose derived stem cells (ASCs) are used by physicians for a variety of indications. Most commonly, ASCs are isolated at the point of care from lipoaspirate (derived from liposuction) tissue as...

Read More

Global Stem Cells group to Launch New Clinical Site in Quito, Ecuador with an Inaugural Conference and Stem Cell Training Event

Global Stem Cells Group has announced plans to inaugurate its new stem cell center in Quito, Ecuador with an inaugural conference and stem cell training event Feb. 24-March 6. The new facility will offer the latest stem cell therapies to treat a variety of patient needs. MIAMI, Feb. 22, 2016—Global Stem Cells Group, has announced an inaugural conference and stem cell training event to launch its new stem cell treatment in Quito, Ecuador. Feb. 24-March 6, 2016 launch of a new stem cell treatment center in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine to patients from around the world. Global Stem Cells Group CEO Benito Novas will host the event, which will begin with a stem cell conference featuring...

Read More

Global Stem Cells Group Announces New Clinic Opening in Quito, Ecuador

Global Stem Cells Group has announced the opening of a new stem cell clinic in Quito, Ecuador. The new facility will offer the latest stem cell and regenerative medicine treatments for orthopedic and trauma applications. MIAMI, Feb. 11, 2016—Global Stem Cells Group, has announced the opening of its new stem cell treatment clinic in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, focusing on orthopedic and trauma applications to patients from around the world. [caption id="attachment_13970" align="alignleft" width="139"] Pablo Cornejo, MD[/caption] The new GSCG clinic is headed by four prominent Ecuadorian physicians, including Pablo Ramos, M.D. an orthopedic specialist and attending physician at Metropolitan Hospital in Quito; Pablo Cornejo, M.D., a specialist in orthopedic and trauma surgery at Metropolitan Hospital, Quito;...

Read More

Global Stem Cells Group Named Authorized Distributor of GMTN Exosome Injection and Other Biological Products

Global Stem Cells Group, a world leader in regenerative medicine, has announced a new agreement with Bankok,Thailand-based Global Stem Cells Network (GSCN) to distribute exosome injection and other biological products to stem cell researchers and phsyicians in 15 Latin American countries, including Mexico, Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El Salvador, Venezuela, Peru, Ecuador, Paraguay, Puerto Rico, Chile Bolivia and Uruguay. The agreement gives Global Stem Cells Group exclusive distribution rights for the following GSCN products: Exosome Injection, a human induced pluripotent stem cell-derived mesenchymal stem cell treatment, which has emerged as a promising supplement to stem cell transplantation therapies. Exosomes derived from mesenchymal stem cells can play an important role in repairing injured tissues. Exosome injection is also utilized as a complement to bone...

Read More
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LnlvdXR1YmUuY29tL2VtYmVkL2phRHdSdk95SEs4P3JlbD0wJmF1dG9wbGF5PTEiZnJhbWVib3JkZXI9IjAiIGFsbG93ZnVsbHNjcmVlbj48L2lmcmFtZT4=
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LnlvdXR1YmUuY29tL2VtYmVkL0FBdUpNaTFIZzZzP3JlbD0wJmFtcDtzaG93aW5mbz0wIiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LnlvdXR1YmUuY29tL2VtYmVkL2phRHdSdk95SEs4P3JlbD0wJmF1dG9wbGF5PTEiZnJhbWVib3JkZXI9IjAiIGFsbG93ZnVsbHNjcmVlbj48L2lmcmFtZT4=